vimarsana.com

Latest Breaking News On - Ravi penmetsa - Page 1 : vimarsana.com

Gland Pharma shares fall 6% as ex-promoter likely sells stake in block deals

Shares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deals of 91 lakh shares worth Rs 1,600 crore reported.

Ravi penmetsaNicomac machinery rp advisory servicesAxis bankGland pharmaBain capitalEribulin mesylate injectionGland pharma share priceGland pharma stock priceGland pharma stock newsGland pharma block deal

Stock Market Today: Top 10 things to know before the market opens

Trends in the GIFT Nifty indicate a strong start for the broader index in India, with a gain of 59.50 points or 0.28 percent.

United kingdomIsrael generalUnited statesRavi penmetsaNicomac machinery private ltdRp advisory services private ltdTata motorsAxis bankDow jones industrial averageNasdaq compositeWall streetBain capitalBofa securitiesServices private ltdGland pharmaJaguar land rover

Gland Pharma Stock Plunges Following Promoter Stake Sale

Gland Pharma's stock fell 6% from the previous close after the trade and was trading at ₹1,751 on the National Stock Exchange.

Ravi penmetsaNicomac machinery private ltdRp advisory servicesRp advisory services private ltdNational stock exchangeGland pharmaNational stockNicomac machinery privateServices private ltdNicomac machinery

Moneycontrol Daily: Your Essential 7

Here are stories covering a range of topics to keep you informed as you start your day. Read important details from each article and follow the provided links to read more about each story.

Ravi penmetsaNicomac machinery private ltdRp advisory services private ltdGland pharmaServices private ltdMc essentialsOneycontrol dailyYour essential 7Moneycontrol essential 7Mc essential 7Daily essentialsDc daily

Block deal in Gland Pharma as ex-promoter offloads stake worth Rs 1,590 crore

Nicomac Machinery Private Ltd and RP Advisory Services Private Ltd, the two entities linked to the former promoter of Gland Pharma, were looking to unload a 4.4 percent stake in the drug manufacturer

Ravi penmetsaRp advisory services private ltdRp advisory servicesNational stock exchangeNicomac machinery private ltdGland pharma block dealGland pharmaNational stockServices private ltdLock dealUzzing stocksGland pharma block deal

vimarsana © 2020. All Rights Reserved.